Open access
Open access
Powered by Google Translator Translator

Cardiology (all articles)

EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices.

5 Apr, 2022 | 08:39h | UTC

EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices – EP Europace

News Release: Advice to prevent consequences of interference in cardiac device patients published today – European Society of Cardiology

 

EHRA practical guide: How to use digital devices to detect and manage arrhythmias.

5 Apr, 2022 | 08:41h | UTC

How to use digital devices to detect and manage arrhythmias: an EHRA practical guide – EP Europace

News Release: Advice on how to use digital devices to detect and manage arrhythmias published today – European Society of Cardiology

 

Review: Antiplatelet therapy after percutaneous coronary intervention.

5 Apr, 2022 | 08:38h | UTC

Antiplatelet therapy after percutaneous coronary intervention – EuroIntervention

 

Commentary on Twitter

 

Expert Consensus Statement on the state of genetic testing for cardiac diseases.

5 Apr, 2022 | 08:31h | UTC

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases

News Release: Recommendations on genetic testing for inherited cardiac diseases published today – European Society of Cardiology

 

Commentary on Twitter

 

Cohort Study: Childhood cardiovascular risk factors and adult cardiovascular events.

5 Apr, 2022 | 08:23h | UTC

Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 

Pericardial effusion and cardiac tamponade: pearls and pitfalls.

5 Apr, 2022 | 08:13h | UTC

Pericardial Effusion and Cardiac Tamponade: Pearls and Pitfalls – emDocs

 

Systematic Review: Endovascular vs. conventional open surgical repair for thoracoabdominal aortic aneurysms.

5 Apr, 2022 | 08:11h | UTC

Endovascular versus conventional open surgical repair for thoracoabdominal aortic aneurysms – Cochrane Library

Summary: Are patient outcomes superior after endovascular or open surgical repair of thoracoabdominal aortic aneurysms? – Cochrane Library

 

Commentary on Twitter

 

#ACC22 – 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.

4 Apr, 2022 | 01:42h | UTC

ACC Guideline Hub: Heart Failure

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines – Journal of the American College of Cardiology

Executive Summary: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

News Release: ACC, AHA, HFSA Issue Heart Failure Guideline – American Heart Association

Key Perspectives: 2022 AHA/ACC/HFSA Heart Failure Guideline

Slide Set Download: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

Flipbook

 

Commentary on Twitter

 

Cohort Study: Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.

5 Apr, 2022 | 08:03h | UTC

Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis – European Heart Journal

Editorial: Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting – European Heart Journal

Related: Cohort Study: High-sensitivity Troponin I after cardiac surgery and 30-day mortality.

 

Commentary on Twitter

 

#ACC22 – RCT: Treatment for mild chronic hypertension during pregnancy is associated with better pregnancy outcomes than a strategy of reserving treatment only for severe hypertension.

4 Apr, 2022 | 01:34h | UTC

Treatment for Mild Chronic Hypertension during Pregnancy – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

Treating chronic hypertension in early pregnancy benefits parents, babies – NIH News Releases

CHAP: Treating Mild Chronic HTN is Associated With Better Pregnancy Outcomes – American College of Cardiology

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes – TCTMD

 

Commentary on Twitter

 

#ACC22 – RCT: Among ambulatory patients with heart failure, a dietary intervention to reduce sodium intake did not reduce clinical events.

4 Apr, 2022 | 01:32h | UTC

Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial – The Lancet (free registration required)

Commentaries:

SODIUM-HF: No Impact of Dietary Salt Restriction on Death or Hospitalization – TCTMD

SODIUM-HF: Does Strictly Limiting Sodium Intake Reduce Cardiac Events, Improve QOL in HF Patients? – American College of Cardiology

Hold the salt: Study reveals how reducing sodium intake can help patients with heart failure – University of Alberta

 

Commentary on Twitter

 

#ACC22 [Not published yet] – RCT: Mavacamten reduces the need for surgical intervention in patients with obstructive hypertrophic cardiomyopathy.

4 Apr, 2022 | 01:13h | UTC

VALOR-HCM: Mavacamten Significantly Reduces Need For Surgical Intervention in Patients With Obstructive HCM – American College of Cardiology

Commentaries:

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM – TCTMD

Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy – VALOR-HCM – American College of Cardiology

Trial shows drug effective in nearly 80% of patients with hypertrophic cardiomyopathy – Cleveland Clinic

Related: #ESCCongress – Randomized trial: Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy

 

Commentary on Twitter

 

Single-arm cohort study: percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy.

4 Apr, 2022 | 01:10h | UTC

Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy – JAMA Cardiology (free for a limited period)

Invited Commentary: Septal Reduction Strategies in Hypertrophic Cardiomyopathy—The Scalpel, Catheter, or Wire? – JAMA Cardiology (free for a limited period)

Video: Percutaneous Intramyocardial Septal Radiofrequency Ablation

 

Commentary on Twitter

 

#ACC22 – RCT: Diltiazem did not significantly improve coronary vasomotor dysfunction in angina and nonobstructive coronary arteries.

4 Apr, 2022 | 01:09h | UTC

Efficacy of Diltiazem to improve coronary vasomotor dysfunction in angina and nonobstructive coronary arteries (ANOCA): Results of the EDIT-CMD randomized clinical trial – JACC: Cardiovascular Imaging (link to abstract – $ for full-text)

Commentaries:

In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD – TCTMD

EDIT-CMD: Diltiazem Not Effective in Reducing Coronary Vasomotor Dysfunction, Improving Angina or QOL in ANOCA Patients – American College of Cardiology

 

Commentary on Twitter

 

Registry-based cohort study | recurrent mitral regurgitation after MitraClip: predictive factors, morphology, and clinical implication.

4 Apr, 2022 | 00:55h | UTC

Recurrent Mitral Regurgitation After MitraClip: Predictive Factors, Morphology, and Clinical Implication – Circulation: Cardiovascular Interventions

 

Commentary on Twitter

 

State of the Art Review: The heart brain team and patient-centered management of ischemic stroke.

1 Apr, 2022 | 09:53h | UTC

The Heart Brain Team and Patient-Centered Management of Ischemic Stroke – JACC: Advances

 

Consensus Statement: Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease.

1 Apr, 2022 | 08:51h | UTC

Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership – Heart

 

Genetic testing identified a disease-causing variant in 10% of unexplained cardiac arrest survivors.

1 Apr, 2022 | 08:47h | UTC

Importance of genetic testing in cardiac arrest – European Heart Journal

 

Commentary on Twitter

 

Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.

1 Apr, 2022 | 08:45h | UTC

Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials – eBioMedicine

Commentary: Network meta-analysis rates treatments for Kawasaki disease – medwire News

 

Meta-analysis of randomized trials: Clopidogrel is better than aspirin for the secondary prevention of cardiovascular events.

31 Mar, 2022 | 08:31h | UTC

P2Y12 Inhibitor versus Aspirin Monotherapy for Secondary Prevention of Cardiovascular Events: Meta-Analysis of Randomized Trials – European Heart Journal Open

Commentary: Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention – TCTMD

 

Commentary on Twitter

 

Review | Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care.

31 Mar, 2022 | 08:09h | UTC

Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care – ESC Heart Failure

 

AHA/ASA Scientific Statement: Endovascular treatment and thrombolysis for acute ischemic stroke in patients with premorbid disability or dementia.

30 Mar, 2022 | 10:33h | UTC

Endovascular Treatment and Thrombolysis for Acute Ischemic Stroke in Patients With Premorbid Disability or Dementia: A Scientific Statement From the American Heart Association/American Stroke Association – Stroke

News Release: Stroke treatments safe and effective for people with existing disability or dementia – American Heart Association

 

Commentary on Twitter (thread – click for more)

 

Review: Sudden cardiac death in congenital heart disease.

30 Mar, 2022 | 10:17h | UTC

Sudden cardiac death in congenital heart disease – European Heart Journal

 

Commentary on Twitter

 

End-of-life care in the cardiac intensive care unit: a contemporary view from the Critical Care Cardiology Trials Network (CCCTN) Registry.

30 Mar, 2022 | 10:08h | UTC

End-of-life care in the cardiac intensive care unit: a contemporary view from the Critical Care Cardiology Trials Network (CCCTN) Registry – European Heart Journal. Acute Cardiovascular Care

 

Commentary on Twitter

 

Cohort Study: Socio-economic variations determine the clinical presentation, etiology and outcome of infective endocarditis.

30 Mar, 2022 | 09:50h | UTC

Socio-Economic Variations Determine the Clinical Presentation, Aetiology and Outcome of Infective Endocarditis: a Prospective Cohort Study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) Registry – European Heart Journal – Quality of Care and Clinical Outcomes

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.